CARE & CURE NUTRACEUTICALS LTDActive

Company number 07951499Private limited companyIncorporated 2012

Key figures

£3,895+104.9%
Net assets 2024/25
-31.2%
Average annual change 2019/20–2024/25
-100 k-50 k050 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, CARE & CURE NUTRACEUTICALS LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
050 k100 k150 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand—34,22917,56615,14735,938
Total assets43,54051,58147,48643,33761,608
Total liabilities40,820—127,791122,46257,713
Net assets / total equity2,720-79,030-80,305-79,1253,895
Average number of employees52022

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: CARE & CURE NUTRACEUTICALS LTD

Company

CARE & CURE NUTRACEUTICALS LTD is a private limited company registered with Companies House under company number 07951499. It was incorporated on 15 Feb 2012. Its status is active. The registered office is in Morden (SM4). Its nature of business (SIC 2007) is other business support service activities n.e.c. (82990).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files small company accounts (filleted). Net assets were £3,895, up 104.9% on the previous year. Cash at bank and in hand was £35,938. Total assets were £61,608 and total liabilities £57,713. The company had an average of 2 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 1 Mar 2027.